ABSTRACT
The authors present the French concept of a mobile neurosurgical unit (MNSU) as used to provide specific support to remote military medicosurgical units deployed in Africa, South America, Central Europe, and Afghanistan. From 2001 to 2009, 15 missions were performed, for 16 patients. All but 3 of these missions (those in Kosovo, French Guyana, and Afghanistan) concerned Africa. Eleven patients were French soldiers, 3 were civilians, and 2 were Djiboutian soldiers. The conditions that MNSUs were requested for included craniocerebral wounds (2 cases), closed head trauma (7 cases), spinal trauma (5 cases), and spontaneous intracranial hemorrhage (2 cases). In 5 of the 16 cases, neurosurgical treatment was provided on site. All French soldiers and 2 civilians were evacuated to France. The MNSU can be deployed for timely treatment when some delay in neurosurgical management is acceptable.
Subject(s)
Ambulances/organization & administration , Military Medicine/organization & administration , Neurosurgery/organization & administration , Transportation of Patients/organization & administration , Adult , Case Management/organization & administration , Child, Preschool , Craniocerebral Trauma/surgery , France , Humans , Male , Military Medicine/methods , Neurosurgery/methods , Telemedicine/methods , Telemedicine/organization & administration , Telemedicine/statistics & numerical data , Transportation of Patients/methods , WarfareSubject(s)
Adrenergic beta-Antagonists/adverse effects , Coronary Disease/drug therapy , Coronary Stenosis/chemically induced , Diskectomy , Lumbar Vertebrae/surgery , Myocardial Ischemia/chemically induced , Aged , Angioplasty, Balloon, Coronary/instrumentation , Coronary Disease/complications , Coronary Disease/physiopathology , Coronary Stenosis/physiopathology , Coronary Stenosis/therapy , Hemodynamics/drug effects , Humans , Male , Myocardial Ischemia/physiopathology , Myocardial Ischemia/therapy , Perioperative Care , StentsABSTRACT
A case of a patient who was admitted to hospital in Paris, France, in February 2001 with autoimmune haemolytic anaemia, probably due to artemether-lumefantrine therapy, is presented. Such a complication has previously been observed in patients receiving drugs containing aryl-amino-alcohols but never before in a patient receiving lumefantrine and may be associated with the increase in episodes of blackwater fever seen in recent years.
